ANTX ▼ -0.2% - AN2 Therapeutics, Inc.
$ANTX - AN2 Therapeutics Advances Pipeline With Development Candidate Nomination for Hypophosphatasia (HPP)
04-NOV-2026 07:09 AM ET
Share this post
More filings for $ANTX
ANTX ▲ +1.4% - AN2 Therapeutics, Inc.Nov 4, 2026ANTX ▲ +5.6% - AN2 Therapeutics, Inc.Oct 20, 2026ANTX ▼ -0.4% - AN2 Therapeutics, Inc.Sep 16, 2026
View full $ANTX filing history →💬 Comments
Loading comments…
Leave a comment